Figure 1. Barriers to clinical trial access identified by four key stakeholder groups: patient advocates, community oncologists, industry partners, and academic oncologists.
Created in BioRender. Ebrahimi, H. (2025) https://app.biorender.com/citation/67f7306640df716b6b1d1c18
Copy bibliographic reference (APA Style)
Ebrahimi, H. (2025). Figure 1. Barriers to clinical trial access identified by four key stakeholder groups: patient advocates, community oncologists, industry partners, and academic oncologists.. Created in BioRender. https://app.biorender.com/citation/67f7306640df716b6b1d1c18